ArticleMolecules (Basel, Switzerland)2026
Comparative Transcriptomic Analysis Provides Insights into PSK-α-Mediated Regulation of Diosgenin Biosynthesis in
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Diosgenin is an important steroidal sapogenin widely used for the industrial production of steroidal drugs. Phytosulfokine-α (PSK-α) is a sulfated pentapeptide hormone known to regulate plant growth, development, and stress responses. However, its role in the regulation of diosgenin biosynthesis remains unclear. Fenugreek seedlings were treated with PSK-α to investigate its effects on diosgenin biosynthesis through metabolite profiling and comparative transcriptomic analyses. PSK-α induced a dynamic response in diosgenin accumulation, characterized by an initial decrease during the early stage of treatment followed by a gradual increase, ultimately resulting in 61.4% and 72.1% increases in diosgenin accumulation after 10 days and 15 days, respectively, compared with the corresponding random pentapeptide control. Comparative transcriptomic analysis between PSK-α-treated seedlings and the corresponding controls at 5 and 15 days identified key genes or transcript isoforms involved in diosgenin biosynthesis, PSK signaling and MAPK signaling pathways. Meanwhile, five candidate genes involved in diosgenin biosynthesis and PSK signaling exhibited expression patterns consistent with the dynamic accumulation pattern of diosgenin. To further dissect the regulatory network, co-expression network analysis between these 28 candidate genes involved in diosgenin biosynthesis and PSK signaling and 1407 transcription factor-encoding genes identified candidate transcription factors potentially involved in the coordinated regulation of diosgenin biosynthesis and PSK signaling. This study suggests that PSK-α may contribute to enhanced diosgenin accumulation through coordinated transcriptional regulation of diosgenin biosynthesis and PSK signaling pathways, providing new insights into the regulation of plant secondary metabolism by peptide hormones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.